Since its implementation in December 2016, use of a ceftolozane-tazobactam order set at Marin General Hospital has advanced antimicrobial stewardship efforts.
Contagion® editor-in-chief, Jason C. Gallagher, PharmD, FCCP, FIDSA, BCPS, affirms that the health care industry needs to hit the reset button on how antibiotics are developed.
A new report from researchers at the Centers for Disease Control and Prevention details the investigational use of a drug to treat Chagas disease now available commercially in the United States.
